All trading involves risk. Losses can exceed deposits.

DAX flat after IFO report

The Germany 30 is broadly unchanged as the German IFO business climate report drops in June.

All trading involves risk. Losses can exceed deposits.
Frankfurt stock exchange
Source: Bloomberg

The Germany 30 is trading at 9928 after the weaker-than-expected IFO number pushed the German equity benchmark towards the 9900 mark. The index has not recovered from the selloff in early trading when the market plunged from 10,000 to sub 9900 in quick succession.

The German inflation report on Friday will be the focus of the week, and the consensus is for an increase of 0.2% for the month of June. The cost of living in Germany is still increasing, and the European Central Bank is less likely to introduce additional monetary easing.

As Chris Beauchamp stated, the DAX is finding it difficult to maintain its upward trend and it is hanging on to the 9900 level. If the DAX continues to run out of steam it could target the 50-day moving average of 9797. However, if speculation that Mario Draghi will pursue quantitative easing continues, we could see the DAX target 9980.

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.